WebMD Health (WBMD) Updates FY15 Guidance, Discusses FY16 Outlook

Go back to WebMD Health (WBMD) Updates FY15 Guidance, Discusses FY16 Outlook

Leerink Partners Raises PT to $61 Following WebMD Health's (WBMD) Positive 4Q Pre-Announcement

January 13, 2016 7:15 AM EST

Leerink Partners reiterated an Outperform rating on WebMD Health Corp. (NASDAQ: WBMD), and raised the price target to $61.00 (from $60.00), following the company's positive 4Q pre-announcement. WebMD indicated that Q415 revenue and Adj. EBITDA will come in about 2% above prior guided ranges due to strong... More